Introduction
Intrauterine growth is a key determinant of lifespan. Babies born growth restricted or large for gestational age are at greater risk of perinatal morbidity and mortality than those of normal birth weight. Moreover, the 'memories' of an altered environment and growth in utero can stretch beyond the perinatal period to influence health much later in life. Epidemiological studies in humans have shown that babies grown abnormally due to poor maternal nutrition are at heightened risk of developing conditions such as type 2 diabetes, heart disease and obesity as adults, and of dying younger as a consequence (Gluckman et al. 2005; . Similarly, manipulating intrauterine growth experimentally by varying maternal food intake, dietary composition, oxygen availability, endocrine status or utero-placental blood flow has been shown to programme cardiovascular, metabolic and endocrine function of the adult offspring in a wide range of mammalian species (Gluckman et al. 2005; McMillen & Robinson, 2005; Fowden et al. 2006) .
As the interface between the mother and fetus, the placenta is one of the main determinants of intrauterine growth. It supplies all the nutrients and oxygen required for fetal growth as well as secreting hormones that influence maternal metabolism in favour of the fetal needs. Its morphological and functional characteristics, therefore, have an important role in determining the allocation of maternal resources to fetal growth. These characteristics include cell composition, surface area, barrier thickness, blood flow, vascularity, nutrient utilisation and the abundance and activity of the various transporter molecules (Fowden et al. 2009; Sandovici et al. 2012) . Recent studies have shown that the placenta can respond to maternal nutritional and metabolic signals by altering these characteristics which, in turn, leads to changes in the placental capacity to supply resources to the fetus (Fowden et al. 2009; Sandovici et al. 2012) . Thus, the placenta is a key mediator in linking maternal environmental conditions to development of the fetus (Burton et al. 2016; Sferruzzi-Perri & Camm, 2016) . However, the molecular mechanisms by which the placenta senses and responds to environmental cues during pregnancy are poorly understood. This review discusses the role of the insulin-like growth factors (IGFs) in controlling placental resource allocation to intrauterine growth, particularly in relation to maternal environmental conditions during pregnancy. It focuses primarily on small laboratory animals, such as the mice, rats and guinea pigs that are most commonly used for these studies, but also draws on data from other species, including humans, where available.
The insulin-like growth factors
The insulin-like growth factors (IGFs), IGF1 and IGF2, are 7.5 kDa single-chained polypeptides that promote growth, both before and after birth. They affect the metabolism, mitogenesis, survival and differentiation of a wide variety of cell types by binding to IGF receptors (IGF1R and IGF2R), insulin receptor (INSR) and a hybrid IGF1R-INSR receptor with varying affinity (Sferruzzi-Perri et al. 2008; Fernandez & Torres-Aleman, 2012; Harris & Westwood, 2012) . Their actions are influenced by at least six different IGF binding proteins (IGFBP-1 to IGFBP-6) and numerous IGF-related binding proteins, which alter access of the IGFs to their receptors and have been reviewed in detail elsewhere (Bach et al. 2005; Bach, 2015; Clemmons, 2016) . The main signalling receptor for the IGFs is IGF1R, which activates the phosphoinositide-3 kinase (PI3K)-protein kinase B (AKT) and mitogen-activated protein kinase (MAPK) signalling pathways. IGF2 also binds to the IGF2R, which can lead to either IGF2 degradation or activation of the G-protein-coupled signalling pathway (Okamoto et al. 1990) .
The Igf2 gene is subject to parental imprinting and only the paternal allele is expressed. It can be expressed by different promoters, of which P0 (Igf2P0) is specific to the placenta in mice (Moore et al. 1997) . In mice, though largely not in humans, the Igf2r gene is also imprinted but in a reciprocal fashion to Igf2 with expression from the maternal allele (Monk et al. 2006) . The IGFs (particularly IGF2), their receptors and signalling pathways are expressed by the placenta in many species and change in their abundance both developmentally and in response to environmental cues (Sferruzzi-Perri et al. 2010) . In many species, circulating IGF concentrations are higher during pregnancy than in the non-pregnant animal and also change in the mother and fetus with proximity to delivery (Fowden, 2003; Sferruzzi-Perri et al. 2010) . IGF2 is more abundant than IGF1 in both the maternal and fetal circulations in all species studied to date (Fowden, 2003; Sferruzzi-Perri et al. 2010) . IGF2 is also more highly expressed than IGF1 by the placenta in all species studied to date (Sferruzzi-Perri et al. 2010) .
The effects of the insulin-like growth factors on placental phenotype
The effects of the IGFs on the placenta have been studied directly in two main ways. First, they have been given exogenously either to placental cultures in vitro or to pregnant animals in vivo to study placental growth, transport and endocrine function. Secondly, the Igf genes, their receptors and key molecules in their downstream pathways have been under-or over-expressed in genetically modified mice to determine the morphological and functional consequences for the placenta at different stages of pregnancy. While the functions of the placenta are common across species, its structure varies in terms of shape, organisation of trophoblast lineages, extent of invasion into the maternal uterus, and degree of interdigitation at the feto-materno interface (reviewed in depth elsewhere; Carter, 2007; Wooding & Burton, 2008; Roberts et al. 2016) . For instance, the human and non-human primate placenta is composed of a series of highly branched structures, called villi. These contain a mesenchymal core that has fetal capillaries that are closely associated with an overlying syncytiotrophoblast layer. The syncytiotrophoblast is directly bathed in maternal blood and functions in both transport and hormone secretion. Cytotrophoblast cells, can fuse to form the syncytiotrophoblast or migrate from the villous tree into the decidua, where they invade and remodel uterine spiral arteries to promote blood flow to the placenta. The syncytiotrophoblast is also bathed in maternal blood in the mouse, rat and guinea pig placenta. However, the mouse placenta is arranged into two morphologically and functionally distinct regions: the labyrinth zone (Lz), which is responsible primarily for transport, and the junctional zone (Jz; also known as basal or interlobium region), which functions in uterine remodelling/invasion and hormone secretion. In ruminate species like the sheep and cow, the placenta is composed of individual placentomes that form at specialised sites called caruncles in the uterine wall. The overlaying trophoblast layer can be a syncytium (in sheep) or remains unicellular (columnar epithelium in cows) and there no invasion of the maternal blood vessels by trophoblast cells. However, in sheep some trophoblast cells migrate and fuse with caruncle epithelial cells and play an endocrine role.
Exogenous administration of IGFs.
In vitro experiments. IGF1 and IGF2 prevent apoptosis and enhance proliferation and migration/invasion of human placental villous explants, primary trophoblast cultures and trophoblast cell lines from the first trimester and term (Table 1) . IGF1 also promotes the proliferation, invasion and survival of first trimester human placental fibroblasts (Miller et al. 2005 ) and the differentiation of term trophoblast cells into syncytiotrophoblast (Bhaumick et al. 1992; Milio et al. 1994; Cohran et al. 1996) . Similarly, IGF1 stimulates proliferation and migration of murine ectoplacental cone trophoblast in culture (Kanai-Azuma et al. 1993) and early pregnancy porcine trophoblast cells (Jeong et al. 2014) . Furthermore, IGF2 promotes differentiation of murine ectoplacental cone trophoblast and migration of ovine trophoblast cells in vitro (Kim et al. 2008) . Using receptor and pathway inhibitors and IGF analogues with selectivity for particular receptors, some of the molecular mechanisms mediating the actions of IGFs on the human placenta have begun to be identified in vitro. IGFs appear to mediate their proliferative and anti-apoptotic effects on trophoblast through activating IGF1R and triggering the MAPK and PI3K-AKT signalling pathways, respectively (Forbes et al. 2008) . IGFs also induce trophoblast migration and invasion through IGF1R, and possibly INSR, with subsequent activation of MAPK and PI3K-AKT signalling pathways (Diaz et al. 2007; Shields et al. 2007; Forbes et al. 2008; Mayama et al. 2013) . However, IGF2 may also signal via IGF2R and G i proteins, MAPK and Rho GTPase pathways to trigger trophoblast migration and invasion (McKinnon et al. 2001; Shields et al. 2007; Harris et al. 2011) . Thus IGFs promote the growth of different cell lineages in the placenta via multiple mechanisms (Fig. 1A) .
In addition to stimulating placental growth, both IGFs stimulate glucose and System A amino acid uptake, and IGF1 increases System L activity but reduces lipoprotein lipase activity in human trophoblast in vitro (Table 1) . However, these changes in nutrient uptake do not always track with the expression of the transporter genes or proteins, suggesting that the IGFs may also affect post-transcriptional/translational mechanisms (Fang et al. 2006; Jones et al. 2013 Jones et al. , 2014 . Indeed, IGF1 was recently shown to stimulate glucose transporter capacity by increasing the translocation of glucose transporter 1 (GLUT1/SLC2A1) to the trophoblast plasma membrane (Baumann et al. 2014) . In culture, IGF1 prevents the release of the vasoconstrictors prostaglandin E and F and thromboxane by the term human placenta and reduces the agonist-mediated vasoconstriction of human myometrial arteries (Siler-Khodr et al. 1995; Corcoran et al. 2012) .
In vivo, these effects could increase utero-placental blood flow and substrate transfer in late gestation. Both IGF1 and IGF2 also enhance trophoblast endocrine capacity in culture. IGFs increase the secretion of hormones including progesterone, human chorionic gonadotrophin and placental lactogen in vitro although others, like placental growth hormone may not be affected (Maruo et al. 1995; Zeck et al. 2008; Rak-Mardyla & Gregoraszczuk, 2010) . In addition, IGF2 simulates the differentiation of hormone-producing murine and ovine trophoblast in vitro (Kanai-Azuma et al. 1993; Kim et al. 2008) . Thus, IGFs have the capacity to promote growth, hormone secretion and substrate transport capacity of the placenta.
In vivo experiments. Treatment of guinea pig dams with either IGF1 or IGF2 in early-mid pregnancy increases fetal weight near term (Table 1; Sferruzzi-Perri et al. 2006) . With exogenous IGF1, placental Lz area and Igf2 gene expression is reduced during the treatment, even though fetal weight is increased already in mid pregnancy Sferruzzi-Perri et al. 2007b; Standen et al. 2015) . Whilst there is no sustained effect of either IGF on placental weight, IGF2 increases the volume and surface area of the transport Lz, near term (Table 1; Sferruzzi-Perri et al. 2006) . Development of the placental exchange region was further enhanced when the IGF2R-selective synthetic analogue Leu 27 -IGF2 was administered maternally (Sferruzzi-Perri et al. 2008) . In mice, maternal Leu 27 -IGF2 treatment from day 13 of pregnancy halves the number of fetuses naturally growth restricted within the litter near term (Charnock et al. 2016) . Taken together, these findings suggest that maternal IGF2 in early gestation may act, in part, via the IGF2R to enhance functional development of the placenta with beneficial impacts on fetal growth. However, caution is warranted as part of the effects of Leu 27 -IGF2 could be due to the displacement of endogenous IGF2 and its subsequent interaction with IGF1R and INSR in the placenta.
Exogenous IGFs also modify the functional capacity of the placenta to supply resources for fetal growth. In the late pregnant ewe, increasing IGF1 in the fetal circulation increases amino acid and glucose uptake by the placenta but may reduce materno-fetal transfer of these substrates, lactate production and the number of placentomes (Table 1) . Increasing IGF1 in the maternal circulation also alters placental metabolic function in the pregnant ewe near term; glucose transfer capacity and lactate production are enhanced by an acute infusion of IGF1 . In guinea pigs, placental delivery of glucose and/or neutral amino acids to the fetus is increased in late gestation by chronic maternal IGF treatment in early-mid pregnancy (Table 1) . This enhanced placental transfer in late gestation is partly due to increased expression of nutrient transporters (System A amino acid; SNAT2/Snat2/Slc38a2) by IGF1 in mid pregnancy and improved development of the Highlights details about the administration of IGF. For in vivo studies, exogenous IGF was administered to the mother, unless stated otherwise. Genes are written in lower case and proteins are written in capital. Abbreviations: Ad, Adenoviral-mediated; BT, barrier thickness; D, day; FC, fetal capillaries; GLUT, glucose transporter; hCG, human chorionic gonadotrophin; hPL, human placental lactogen; IGF1/Igf1, insulin-like growth factor-1; IGF2/Igf2, insulin-like growth factor-2; Jz, junctional zone; LAT, L-type amino acid transporter; Lz, labyrinthine zone; MAPK, mitogen activated protein kinase; MBS, maternal blood space; ND, not determined; P4, progesterone; PI3K, phosphoinositol 3-kinase; pGH, placental growth hormone; Prl; prolactin-related hormone; SA, surface area; SNAT/Snat, sodium-coupled amino acid transporter; UN, undernutrition; vol, volume; vd, volume density. Search terms used to find studies listed in the table: trophoblast, placenta, fetus, insulin-like growth factor, IGF and/or transport. exchange region by IGF2 in late pregnancy (Sferruzzi-Perri et al. 2006 . In mice, the variability in System A amino acid transport capacity and conceptus weight within the litter is abolished by maternal Leu 27 -IGF2 (Charnock et al. 2016) and data suggest that IGFs may have most benefit for improving growth of the smallest pups. Indeed, maternal Leu 27 -IGF2 improves the weight of fetuses that are growth restricted due to a lack of the endothelial nitric oxide gene and reduces the number of pups below the fifth centile of the wild-type population in late gestation (Charnock et al. 2016) . In addition to improving placental transport function, exogenous IGFs also affect endocrine capacity in vivo (Fig. 1B) . Maternal IGF2 treatment simulates the development of the endocrine Jz of the rat placenta (Van Mieghem et al. 2009 ) and exogenous IGF1 and IGF2 increase placental pro-renin activation in guinea pigs (Standen et al. 2015) . Thus, IGFs may also increase fetal resource supply through changing placental endocrine function and thus maternal adaptations to pregnancy, but further studies are warranted.
To circumvent possible confounding effects of systemic IGF treatment on the mother, approaches are being developed to target IGFs to the placenta. In mice, adenoviral-mediated site-specific intraplacental transfer of the Igf1 gene on day 14 of pregnancy increases the area of the placenta and the size of the Lz and of the maternaland fetal-facing areas 3 days later, although there is no change in conceptus weight (Table 1 ; Katz et al. 2009 ). In response to liposome-mediated targeting of IGF2 to the mouse placenta, placental growth is also increased although fetal weight is not affected (King et al. 2016) . In rabbits, the weight of natural runt fetuses in the litter is increased 2 days following placental Igf1 transgene delivery without a change in placental weight, but how it impacts on structure and function of the placenta remains unknown (Keswani et al. 2015) . These data suggest that targeting of IGF delivery to the placenta may prove an effective method of improving placental function and thus fetal growth, particularly when feto-placental growth is impaired.
Genetic manipulation of the IGF system. In mice, knockout of the Igf2 gene in the entire conceptus or within the fetal or trophoblast cell lineages leads to placental and fetal growth restriction, with the greatest reduction in growth seen with ubiquitous Igf2 loss (Table 2) . Similarly, a heterozygous deficiency in the PI3K-p110α (Pik3ca; homozygous deficiency is lethal) or complete ablation of the AKT1 (Pkba) or MAPK1 (Erk2) genes causes feto-placental growth restriction (Cho et al. 2001; Hatano et al. 2003; Yang et al. 2003; Yung et al. 2008; Kent et al. 2012; ). In contrast, over-expressing the Igf2 gene through activating the normally silent maternal gene copy in the H19 null, increasing IGF2 availability via Igf2r ablation, or deletion of the PI3K signalling inhibitor (Pten) results 
Global decreased AKT signalling through increased PTEN Ludwig et al. (1996) ; Louvi et al. (1997) Global IGF2 over-expression * Maternal H19 13- and Pten +/- Church et al. (2012) Global increased pAKT in over-growth of the fetus and placenta (Leighton et al. 1995; Ludwig et al. 1996; Louvi et al. 1997; Ripoche et al. 1997; Church et al. 2012) . Deletion of the Igf1, Igf1r or Insr genes in mice also leads to fetal growth restriction, but placental weight is unaffected (DeChiara et al. 1990; Baker et al. 1993; Louvi et al. 1997) . This suggests that the growth-promoting effect of IGF2 in the mouse placenta occurs independently of IGF1R and INSR, possibly through an unknown, distinct placenta-specific receptor (XRp) (Louvi et al. 1997) . However, evidence from H19 null mutants suggests that IGF1R could contribute to the control of placental growth in mice as the first exon of the H19 gene encodes miR-675, which targets Igf1r for reduced expression (Keniry et al. 2012) . Overgrowth of the H19 null placenta (Leighton et al. 1995; Esquiliano et al. 2009; Angiolini et al. 2011; Church et al. 2012 ) is thus thought to be due to biallelic Igf2 via imprinting mechanisms, as well as enhanced Igf1r expression through loss of miR-675 (Keniry et al. 2012) . Taken together, these data highlight the importance and complexity of the IGF system in controlling conceptus growth in mice.
Genetic manipulations of Igf2, Igf2r and the downstream signalling pathways also affect the morphology of the placenta (Table 2 ). For instance, loss of Igf2 (complete and Igf2P0 null), Pik3ca, Pkba or Erk2 gene expression causes defective Lz formation. In particular, Lz volume/thickness, exchange surface area and vascularisation are all reduced and the interhaemal barrier to diffusion of gases such as oxygen is greater in the placenta of all these mutants (Table 2 ). In contrast, in the H19 null, the Lz surface area is increased in line with the placentomegally observed (Angiolini et al. 2011 ). In addition, IGF2 affects the formation of endocrine cells in the placenta. In particular, loss or gain of Igf2 or the PI3K-AKT signalling pathway causes a disproportionate decrease or expansion of the glycogen cells in the Jz, whereas Igf1r or Insr nulls show no changes in Jz glycogen cell abundance (Table 2) . Collectively, the available data suggest that IGF2 acts via both the PI3K-AKT and MAPK pathways to attain normal placental weight and Lz structure, and through PI3K-AKT signalling to drive placental glycogen cell formation in mice (Fig 2A) .
Placental function also changes when the IGF system is genetically modified in mice ( Table 2 ). The passive permeability of the placenta to hydrophilic nutrients/solutes is reduced in the complete Igf2 null, placental-specific Igf2P0 null and H19 null (Constancia et al. 2002; Sibley et al. 2004; Angiolini et al. 2011) . The complete Igf2 null placenta transports less neutral amino acid (methyl aminoisobutyric acid, MeAIB) via the System A transporters in association with reduced SNAT2/Snat2/Slc38a2 expression (Constancia et al. 2005) . There is also reduced abundance of System X AG -and System Y + transporters, responsible for placental transfer of cationic and anionic amino acids, in the complete Igf2 and the Igf1r null (Matthews et al. 1999) . In contrast, the Igf2P0 null placenta transports more neutral amino acids via System A, as well as more glucose and calcium in late gestation (Table 2) . Up-regulation of placental transport capacity is associated with increased expression of SNAT4/Snat4/Slc38a4 and GLUT3/Glut3/Slc2a3 by the Igf2P0 deficient placenta. In contrast to Igf2, there is little or no information on the capacity of the Igf1 or Insr null placenta to supply nutrients to the fetus. In the complete Igf2 null, placental and fetal growth restriction occurs concurrently and becomes evident in mid-gestation (Table 2 ; Baker et al. 1993; Constancia et al. 2005) . In the Igf2P0 null, placental weight is reduced at a similar time in gestation, but fetal growth only becomes restricted much closer to term and to a lesser extent than in the complete Igf2 null Constancia et al. 2002 Constancia et al. , 2005 . Liposome-mediated targeting of IGF2 to the placenta has recently been shown to increase the weight of Igf2P0 null mouse fetuses near term (Table 1 ; King et al. 2016) . Collectively, these findings suggest that the Igf2P0 null placenta compensates for its defective development and compromised permeability by adaptively up-regulating its nutrient transport systems and thereby minimises the degree of fetal growth restriction, relative to the complete Igf2 null. The Pik3ca heterozygote deficient placenta also transfers glucose and amino acids via System A transporters with increased efficiency in compensation for its impaired development, which is associated a less severe reduction in fetal weight close to term than earlier in gestation . Moreover, the naturally small placenta that supports more fetal mass per gram shows increased expression of Igf2P0 coupled with a preservation of Lz growth and with increased placental System A transport capacity and SNAT2/Snat2/Slc38a2 abundance compared to the large placenta in the litter . In contrast, the over-grown H19 null placenta shows diminished neutral amino acid and glucose transport, which is thought to limit fetal over-growth and avoid an excessive drain of maternal resources into the fetus (Angiolini et al. 2011) . Thus, IGF2 in the placenta is important for fine-tuning nutrient supply to the fetus (Fig. 2B) .
In addition to effects on placental transport, the Igf2 gene may also affect the endocrine function of the placenta with consequences for maternal physiology during pregnancy. Evidence for this stems from associations between altered placental Jz formation in H19 and Igf2P0 null mutants and raised circulating glucose, insulin and/or corticosterone in phenotypically wild-type dams (Petry et al. 2010; Sferruzzi-Perri et al. 2011) . Thus, IGF2 has an important role in nutrient allocation to the fetus. By regulating placental phenotype, it balances the fetal genetic drive for growth with the maternal ability to supply the required resources, thereby optimising both offspring and maternal fitness.
IGFs as environmental signals in regulating placental resource allocation to fetal growth
IGFs may also play an important role in changing placental resource allocation to the fetus in environmentally challenged pregnancies. As Igf1 expression is relatively low in the placenta, studies have largely focused on placental expression of Igf2 and activation of its signalling pathways (Table 3) . However, since the signalling pathways are responsive to both IGFs, the placenta can also respond to changes in circulating IGF1 and IGF2 induced by nutritional or other environmental cues.
Maternal nutrition.
Undernutrition. In mice, guinea pigs and baboons, undernutrition restricts placental growth in association with a decrease in the expression of Igf2 and/or signalling via the PI3K-AKT and MAPK pathways (Table 3 ). There are also reductions in placental vascularisation, exchange surface area, Jz volume and glycogen cell abundance and/or a greater barrier to diffusion with maternal undernutrition in mice and guinea pigs, morphological parameters that were altered similarly by a genetic deficiency in Igf2, Pik3ca, Pkba and Erk2 (Tables 2  and 3) . Together, these studies suggest that decreases in IGF2 expression and signalling within the placenta could underlie the growth and morphological defects observed with maternal undernutrition in these species. In larger animals, the expression of Igf2 and its signalling machinery reduces, is unchanged or even increases in response to undernutrition (Table 3) . For instance, signalling via MAPK and PI3K-AKT in the placenta is up-regulated in nutrient-restricted ewes and heifers (Zhu et al. 2007a,b; Ma et al. 2011) . In these models, changes in signalling relate to a normalisation of placental weight or an increase in placental cotyledon vascularity. They also correlate with a maintenance or restoration of fetal weight in later gestation, despite an exposure to undernutrition. In ewes of a moderate condition, which have the smallest placentas supporting more mass of fetus per gram, placental expression of Igf2 is greatest (Osgerby et al. 2003) . These studies therefore suggest that in larger species, there is morphological adaptation of the placental to an adverse maternal nutritional state through increasing Igf2 and growth signalling locally.
In the undernourished sheep placenta with increased PI3K-AKT and MAPK signalling, the expression of glucose and fatty acid transporters is also increased Sasson et al. (2015) 2.5 times fat Mouse -D28 to D18 D13 Sasson et al. (2015) 2.5 times fat Mouse D1 to 18 Sasson et al. (2015) (Continued) 
Placental embolism Sheep D103 to 109 FATP, fatty acid transport protein; FC, fetal capillaries; GLUT, glucose transporter; GiT, giant trophoblast cells; GlyT, trophoblast glycogen cells; IGF1/Igf1, insulin-like growth factor-1; IGF2/Igf2, insulin-like growth factor-2; Jz, junctional zone; LAT, L-type amino acid transporter; LPL, lipoprotein lipase; Lz, labyrinthine zone; MAPK, mitogen activated protein kinase; MBS, maternal blood space; mTOR, mechanistic target of rapamycin; p, phosphorylation; PI3K, phosphoinositol 3-kinase; Prl, prolactin-related hormone; SA, surface area; SNAT/Snat, sodium-coupled amino acid transporter; UN, undernutrition; vol, volume; vd, volume density. Search terms used to find studies listed in the table: placenta, fetus, insulin-like growth factor, IGF, nutrient restriction, undernutrition, low protein diet, high sugar, high fat, obesogenic, IUGR, PI, hypoxia, uterine ligation, corticosterone, dexamethasone carunclectomy, heat stress and/or diabetes.
acid transporter capacity and glucose transporter gene expression (Pantham et al. 2015 (Pantham et al. , 2016 . Taken together, these studies suggest that IGF2 and the PI3K-AKT and MAPK signalling pathways could also mediate changes in placental transport function during undernutrition. In mice, despite a 20% reduction in maternal food intake and placental growth restriction earlier in gestation, fetal weight is normal until just prior to term (Coan et al. 2010) . This maintenance of fetal growth relates to an initial preservation of Lz development in earlier gestation and an adaptive up-regulation of System A amino acid transporter capacity and SNAT2/Snat2/Slc38a2 expression near term, by the growth restricted undernourished placenta. However, in mice lacking the placental-specific Igf2 isoform (Igf2P0), these adaptations to maternal undernutrition fail to occur. The development of the placental exchange region is compromised earlier in gestation, there is no up-regulation of amino acid transport or SNAT2/Snat2/Slc38a2 expression and reduced SNAT4/Snat4/Slc38a4 abundance near term in Igf2P0 null placentas compared to wild-type in undernourished mice (Sferruzzi-Perri et al. 2011) . As a result, fetal growth is restricted earlier in gestation and more adversely affected near term by undernutrition, in Igf2P0 nulls. The Igf2P0 transcript is, therefore, a major determinant of the environmental modification of placental phenotype with undernutrition in mice. The expression of genes involved in glucose, neutral amino acid and fatty acid transport, as well as the IGF signalling pathways in the human placenta are modified by the diet and physical activity of the mother during pregnancy (Brett et al. 2015) . Thus, the IGF system may also be important for modifying resource capacity of the human placenta in response to changes in the maternal environment.
Low-protein diets. During rodent pregnancy, consumption of an iso-calorific low protein diet has inconsistent impacts on both placental weight and placental Igf2 expression (Table 3 ; Sferruzzi-Perri & Camm, 2016) . However, the nature of the specific effect appears to depend on the degree of protein deprivation, stage of pregnancy studied and sex of the conceptus Coan et al. 2011; Nusken et al. 2011; Gao et al. 2012) . Despite the contrasting results, placental Igf2 expression seems to track positively with the weight of the placenta in mice and rats Nusken et al. 2011; Gao et al. 2012) . For instance, in pregnant mice, low protein diets cause placentomegaly and the degree of placental weight increase relates to the level of Igf2 up-regulation at first appearance of growth enhancement . The variation in placental growth and Igf2 expression observed in different models of protein deficiency could be caused by the content and source of carbohydrate used to maintain calorie intake. Nevertheless, taken together, these findings suggest that at least part of the changes in placental growth seen with protein deprivation could be mediated through local changes in Igf2.
There are also changes in placental transport capacity with gestational protein malnutrition. For instance, in response to a diet with 8% protein, the mouse placenta adaptively transports more glucose to the fetus on day 16 of pregnancy . This up-regulation occurs when placental Igf2 expression is also increased and when fetal growth is maintained despite maternal protein deprivation . A few days later, however, glucose transport is unchanged, System A amino acid transporter abundance is reduced and Igf2 expression no longer increased in the placenta by a low protein diet, and fetal growth restriction ensues . These data suggest that placental Igf2 may be important for adapting nutrient supply to the fetus in response to maternal protein malnutrition in mice. However, there is evidence that pathways downstream of Igf2 may also be important. For instance, the mechanistic target of rapamycin (mTORC1) mediates the mitogenic and metabolic actions of IGFs (Jansson et al. 2012b) . In rats, protein deprivation reduces mTORC1 signalling, Systems A and L amino acid transport, and SNAT2/Snat2/Slc38a2, and L-type amino acid transporter (LAT1/lat1/Slc7a5 and LAT2/Lat2/Slc7a8) expression by the placenta, prior to the appearance of placental and fetal growth restriction Rosario et al. 2011) . These findings suggest that down-regulation of signalling pathways like mTORC1 and amino acid transporters in the placenta could link maternal protein restriction to decreases in fetal growth. The availability of protein and specific amino acids during pre-implantation rodent development is linked to alterations in the expression of genes within the H19-Igf2 locus, mTORC1 signalling and trophoblast cell formation and differentiation with consequences for feto-placental phenotype in late gestation (Kwong et al. 2006; Van Winkle et al. 2006; Eckert et al. 2012; Watkins et al. 2015) . Thus, changes in Igf2 expression and its signalling pathways could be responsive to the availability of nutrients from the earliest stages of development.
Diets with excess sugar and/or fat. The expression of Igf2 and its signalling pathways in the placenta are inconsistently altered by diets with excess sugar and/or fat (Table 3) . Weight of the conceptus may also be reduced, increased or unchanged, depending on the level of fat in the diet, the amount of simple sugars consumed and the timing of the dietary manipulation (Table 3 and reviewed in Sferruzzi-Perri & Camm, 2016) . Part of these variations in Igf2 expression and conceptus growth could be due to the differences in protein and micronutrient intake, as species like mice and rats control their calorie intake tightly (Keesey & Hirvonen, 1997) . In mice fed a diet containing 2.5 times J Physiol 595.15 the fat of the controls, placental weight is reduced in early pregnancy in association with decreases in the expression of Igf2 and signalling machinery, including Mtor (Sasson et al. 2015) . These placental changes accompanied reductions in the expression of System A amino acid transporter, SNAT1/Snat1/Slc38a1, glucose transporter, GLUT1/Glut1/Slc2a1, and/or fatty acid translocase, CD36, depending on the length of high fat feeding and whether the diet was eaten before pregnancy (Sasson et al. 2015) . In over-nourished ewes, placental weight is reduced in mid-gestation in association with decreased activity of the IGF signalling pathway (including activation of IRS1 and mTORC1) and changes in vessel size and density in the placenta (Zhu et al. 2009; Ma et al. 2010) . However, fetal weight is increased along with fatty acid transporters and translocases in the placenta, suggesting that alternative signalling pathways may be activated to adapt placental nutrient supply to the fetus in ewes with excess food intake Tuersunjiang et al. 2013) .
In other studies, increases in the placental IGF system are coupled with improved placental resource allocation to the fetus in dams fed obesogenic diets (King et al. 2013; Sferruzzi-Perri et al. 2013; Diaz et al. 2015; Rosario et al. 2015 Rosario et al. , 2016 . For instance, in mice, consumption of a high sugar and fat diet from day 1 of pregnancy initially causes conceptus growth restriction and morphological defects in the placental Lz. However, fetal weight normalises by term, despite the persistence of placental growth and morphological defects through adaptive up-regulation of glucose and neutral amino acid transport to the fetus by the placenta (Sferruzzi-Perri et al. 2013) . Up-regulation of transport capacity relates to increased expression of GLUT3/Glut3/Slc2a3 and SNAT2/Snat2/Slc38a2, as well as elevated expression of the placental-specific Igf2 isoform and PI3K-AKT signalling in the placenta in dams fed a diet with excess sugar and fat. Obesogenic diets fed from before pregnancy also increase placental nutrient transporter capacity (glucose, Systems A and L amino acid and fatty acids) in line with greater Igf2 or PI3K-AKT and mTORC1 signalling; however, responses varied with the precise composition of the diet and, possibly, fetal sex (King et al. 2013; Aye et al. 2015; Diaz et al. 2015; Rosario et al. 2015 Rosario et al. , 2016 . The expression of IGF signalling machinery (receptors, AKT, mTORC1) and nutrient transporters is also altered in the placenta from obese women; however, the specific nature of these changes appears to depend on the level of maternal body fat mass, gestational weight gain and whether macrosomia is observed (Jansson et al. 2012a; Brett et al. 2016; Martino et al. 2016) . Taken together, these findings suggest that obesity and obesogenic diets alter placental phenotype in association with changes in placental Igf2 system and fetal growth.
Maternal hypoxia. In mice, hypoxia typically reduces fetal growth in a severity-dependent manner without a change in placental weight (Table 3 and reviewed in Sferruzzi-Perri & Camm, 2016) . However, if the hypoxic challenge commences early in pregnancy, placentomegaly is observed in associated with greater maternal blood spaces and activation of the PI3K-AKT and mTORC1 signalling pathways in the placenta (Matheson et al. 2015) . Even though placental weight may not be altered when maternal hypoxia commenced later in pregnancy, placental expression of the IGF system and capacity to supply resources to the fetus is altered (Table 3 ). In particular, placental expression of IGF receptors, INSR and PI3K isoforms is decreased in response to 5 days of 13-10% maternal hypoxia in late mouse gestation, and in 10% hypoxia this effect is due to reductions in maternal food intake Higgins et al. 2015) . However, expression of Igf2, Igf2P0 and activated AKT increases with 13% hypoxia, but is unchanged or even decreased in response to 5 days of 12-10% hypoxia near term Higgins et al. 2015) . In the 13% hypoxic mouse placenta showing increases in Igf2 expression and signalling, there are beneficial changes in Lz structure including improved vascularisation, maternal blood spaces and a thinner diffusion barrier to exchange, changes that would optimise oxygen delivery to the fetus near term Matheson et al. 2015) . There is also greater placental glucose uptake and transport and maintained delivery of neutral amino acids to the fetus when 13% hypoxia occurs in the last third of pregnancy . In contrast, in the 12-10% hypoxic placenta with unchanged or decreased expression of the IGF2 system, the morphology of the placental Lz is compromised, with reductions in maternal blood spaces and surface area and a greater barrier to diffusion, changes that would further limit fetal oxygen supply in hypoxic dams Higgins et al. 2015) . Moreover, placental glucose uptake and transport capacity are not up-regulated or even reduced (less GLUT1/Glut1/Slc2a1) and delivery of neutral amino acids diminished, in dams exposed to 12-10% hypoxia, depending on whether food intake is reduced and the sex of the fetus Higgins et al. 2015) . In culture, 1% hypoxia reduces the outgrowth of mouse ectoplacental cone trophoblast in association with diminished Igf2 expression (Pringle et al. 2007) . Hypoxia (1% oxygen) also diminishes the expression of PI3K-AKT and mTORC1 signalling in human trophoblast cell lines (Yung et al. 2012a ) and modulates IGF1 and IGF2 signalling in early pregnancy placental mesenchymal stem cells (Youssef et al. 2014; Youssef & Han, 2016) . Placental expression of the PI3K-AKT and mTORC1 signalling pathways and GLUT1/Glut1/Slc2a1 expression are decreased in women at 3100 m above sea level who deliver growth-restricted babies (Zamudio et al. 2006; Yung et al. 2012a ). In addition, inducing endoplasmic stress in the mouse placental Jz genetically is associated with defects in PI3K-AKT and mTORC1 signalling, altered IGF2 glycosylation and bioactivity, and with feto-placental growth restriction (Yung et al. 2012b) . Taken together, these findings suggest that activating IGF2 and/or PI3K-AKT signalling in the placenta may be critical for adapting placental resource allocation to the fetus during hypoxia in late pregnancy. They also suggest that the placenta may integrate signals of oxygen and nutrient availability through the IGF2 system to adapt its phenotype and optimise maternal resource supply to fetal growth. Indeed, the mouse Igf2 gene harbours a hypoxia-responsive element in its promoter (Feldser et al. 1999) , as well as CHORE motifs, which bind the glucose-responsive transcription factor, MLX (Hunt et al. 2015) . Therefore, the availability of oxygen and nutrients in utero could have direct effects on placental Igf2. Nutritional and hypoxic challenges alter the concentration of hormones like the glucocorticoid stress hormone and insulin, in the maternal circulation (Sferruzzi-Perri et al. 2011; Cuffe et al. 2014) . Thus, changes in placental phenotype may reflect alterations in the metabolic and endocrine state of the mother.
Maternal endocrine challenges. Endocrine challenges can affect maternal metabolism and utilisation of nutrients and thus the partitioning of resource to the conceptus in pregnancy . Administering corticosterone or the synthetic glucocorticoid dexamethasone to rodents for 3-7 days reduces fetal and placental weights during gestation (Table 3 ; Vaughan et al. 2011) . In mice, corticosterone decreases AKT and mTORC1 activation in association with reductions in feto-placental weight, Lz vascularisation, and glucose and System A amino acid transporter capacity; however, the specific nature of these effects depends on when in pregnancy the over-exposure occurs (Table 3) . Administering the synthetic glucocorticoid dexamethasone reduces the expression of MAPK and weight of placenta in female, but not male, conceptuses and there is no change in glucose and SNAT/Snat/Slc38a amino acid transporters irrespective of fetal sex (Cuffe et al. 2011) . In mice, placental Igf2 expression is unaffected by maternal administration of corticosterone and dexamethasone even though the conceptus may be growth restricted (Cuffe et al. 2011; Vaughan et al. 2012 Vaughan et al. , 2015 . Whereas, restrain stress increases placental Igf2 but does not alter offspring weight in mice (Pankevich et al. 2009 ). In rats, dexamethasone decreases placental Igf2 and the level of activated AKT, particularly in the endocrine Jz (Ain et al. 2005) . In dexamethasone-treated rats, there are reductions in the expression of prolactin-related family genes by the Jz in late gestation, which may influence the maternal adaptations to pregnancy and, thus, alter the fetal supply of nutrients indirectly (Ain et al. 2005) . The expression of Igf2 by the term human placenta is also altered in women with elevated plasma cortisol during pregnancy due to emotional distress (Mina et al. 2015) . Glucocorticoid response elements have been identified in the human Igf1 gene promoter (He et al. 2016) ; however, very little is known about whether glucocorticoids could have direct effects on placental Igf2 expression. Collectively these findings suggest that reductions in the placental IGF2 system and the functional phenotype of the placenta could link elevated maternal glucocorticoids to decreases in fetal growth.
In rats, pre-existing maternal diabetes also alters the expression of the IGF system in the placenta, as well as materno-fetal resource allocation; however, the direction of change depends on how long the dam was insulin deficient/dysglycaemic. For instance, Igf expression and IGF1R activation are elevated in association with greater glycerol and free fatty acid transfer by the placenta and an increase in fetal weight by 13% in rats that are diabetic from neonatal life (White et al. 2015) . Placental lipid transport capacity is also increased in rat dams that are diabetic for 1 week prior to pregnancy (increase in placental lipoprotein lipase); however, the expression of Igf2 and the IGF signalling machinery is decreased and the expression of GLUT1/Glut1/Slc2a1 reduced in association with a more minor increase in fetal weight (by 5%) (Cisse et al. 2013) . Genetically inducing maternal insulin insensitivity by a global heterozygous deficiency in PI3K-p110α signalling capacity in the mouse dam is associated with improved placental Lz development (larger surface area and thinner barrier to diffusion), but reduced glucose transport and expression of nutrient (GLUT1/Glut1/Slc2a1, SNAT1/Snat1/Slc38a1, SNAT2/Snat2/Slc38a2) and prolactin-related family genes near term . However, the specific nature of these placental changes depended on whether the conceptus itself was heterozygous for the PI3K-p110α deficiency . Moreover, there is no effect of maternal heterozygous deficiency in PI3K-p110α signalling on fetal weight in this model, irrespective of fetal genotype . Taken together, these studies suggest that the IGF2-PI3K-p110α system plays an important role in modulating fetal nutrition and growth in response to maternal insulin deficiency and/or insensitivity, by acting at the level of placental transport phenotype.
Other environmental challenges affecting conceptus growth. The expression of Igfs, receptors and signalling machinery in the placenta also changes in response to insults that affect the placental capacity to supply the fetus with nutrients. Such insults include reduced utero-placental blood flow, heat stress and alcohol consumption (Table 3) . Reducing both maternal oxygen and nutrient supply to the conceptus using uterine artery ligation in mice, rats and guinea pigs, or placental J Physiol 595.15 embolism in sheep, reduces placental expression of components of the IGF system in association with defects in placental Lz structure and in transporter expression and activity of the glucose and Systems A and L amino acid transporters (Table 3 ). The extent of these changes, however, depends on timing of the insult in the pregnancy. In sheep, removal of uterine caruncles prior to pregnancy is associated with increased placental Igf2 expression and an adaptive increase in placentome size, trophoblast and maternal capillary volume and surface area, although total placental mass and fetal weight are reduced (Table 3 ; Zhang et al. 2016b) . Acute exogenous IGF1 does not alter nutrient metabolism by the embolised sheep placenta (Table 1 ; Jensen et al. 1999) . However, several doses of intra-amniotic IGF1 increase glucose and Systems A and L amino acid transporter expression by the embolised placenta and improves feto-placental growth in vivo (Table 1 ; Eremia et al. 2007; Wali et al. 2012) . Moreover, in mice with uterine artery ligation, targeting of IGF1 to the placenta using a nanoparticle or adenoviral-mediated approach increases the abundance of glucose and Systems A and L amino acid transporters in the placenta, placental width and fetal growth (Table 1 ; Jones et al. 2013 Jones et al. , 2014 Abd Ellah et al. 2015) . These findings highlight the therapeutic potential of IGFs for improving the capacity of the placenta to supply nutrients to the fetus in compromised pregnancies.
In ewes, heat stress reduces placental growth and glucose transport capacity, as well as altering the expression of IGF1 and IGF2, and AKT, mTORC1 and MAPK signalling pathways during gestation (Table 3 ). In rats, alcohol consumption during the peri-conceptional period leads to late gestational fetal growth restriction but no change in placental weight (Gardebjer et al. 2014) . However, Lz development and Igf1, Igf1r and SNAT2/Snat2/Slc38a2 expression are decreased, but Jz glycogen cell formation, Igf2 and GLUT1/Glut1/Slc2a1 may be increased in response to peri-conceptional alcohol exposure near term (Gardebjer et al. 2014) . This suggests there can be programmed changes in the conceptus leading to alterations in the IGF system and the structural and functional phenotype of the placenta that link the maternal A B Figure 3 . The effect of different environmental manipulations on the placental IGF system and resource allocation phenotype in the mouse A, manipulations that down-regulate IGF2 signalling. B, manipulations that up-regulate IGF2 signalling. AKT, protein kinase B; IGF, insulin-like growth factor; Lz, labyrinthine zone. * Note Igf2P0 is required for the placenta to up-regulate amino acid transport to the fetus in response to maternal undernutrition.
environment from the earliest stages of pregnancy to fetal growth near term.
Conclusions and perspectives
Thus, IGFs are important regulators of placental resource allocation to fetal growth both developmentally and in response to environmental manipulations known to programme the ill health of offspring. They increase placental morphogenesis, substrate transport and hormone secretion, which, in turn promotes fetal growth either directly via the supply of nutrients and oxygen or indirectly via the maternal metabolic adaptation to pregnancy and the availability of nutrients for transplacental transport. In response to environmental challenges, the IGFs (particularly IGF2) and their signalling pathways change in line with the alterations in placental structure and function, and thereby link changes in the maternal environment to fetal substrate supply and growth during pregnancy with implications for developmental programming. The environmentally induced changes in the IGF system and placental phenotype may be beneficial (obesogenic diets, moderate hypoxia and low protein diets) or detrimental (e.g. severe oxygen and nutrient deprivation and glucocorticoid excess) to resource allocation to the fetus depending on the type, severity and timing of the challenge during pregnancy (Fig. 3) . The beneficial effects of IGF treatments on placental phenotype show promising therapeutic potential for improving fetal growth in situations in which placental growth is impaired without major maternal compromise, particularly when the treatment with IGF1 or IGF2 is targeted directly to the placenta. However, efforts to understand the regulation of endogenous placental IGF expression may also be fruitful, particularly in the case of Igf2, which appears to be most important for mediating adaptive responses locally in mice. These findings are important in the context of human pregnancy as dysregulated expression of the IGFs and signalling components are often reported in the human placenta associated with abnormal fetal growth (Abu-Amero et al. 1998; Sheikh et al. 2001; Gratton et al. 2002; Gurel et al. 2003; Laviola et al. 2005; Scioscia et al. 2006; Street et al. 2006; Trollmann et al. 2007; Akram et al. 2008; Yung et al. 2008; Colomiere et al. 2009; Borzsonyi et al. 2011; Street et al. 2011; Demendi et al. 2012; Jansson et al. 2012a; Iniguez et al. 2014; Nawathe et al. 2016; Zhang et al. 2016a) . However, it is important to note that several causes of environmental, maternal and fetal origin can lead to changes in placental phenotype and fetal growth in humans (Gaccioli & Lager, 2016) . Thus studies of animal models showing alterations in the expression of IGFs and their signalling pathways provide insight but further information is required on the natural conditions of variable placental phenotype among humans.
